Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10438
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNg, Stevenen
dc.contributor.authorButzkueven, Helmuten
dc.contributor.authorKalnins, Renate Men
dc.contributor.authorRowe, Christopher Cen
dc.date.accessioned2015-05-15T23:53:12Z
dc.date.available2015-05-15T23:53:12Z
dc.date.issued2007-09-24en
dc.identifier.citationJournal of Clinical Neuroscience 2007; 14(11): 1126-9en
dc.identifier.govdoc17890092en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10438en
dc.description.abstractPrimary central nervous system lymphoma (PCNSL) can be associated with preceding demyelinating pseudotumoral brain lesions. The 'sentinel' demyelinating lesions recede spontaneously or with corticosteroid, and are followed by development of PCNSL typically within 12 months. This report describes a 29 year-old post-partum woman who developed PCNSL 4 years after a biopsy-proven pseudotumoral demyelinating episode. She presented with focal seizures in February 2005. She subsequently developed hemiparesis and raised intracranial pressure. MRI showed two contrast enhancing lesions in the right frontal lobe, which were hypermetabolic on (18)F-FDG PET. A provisional diagnosis of tumefactive multiple sclerosis was made. Symptoms recurred despite multiple courses of high dose corticosteroid. Brain biopsy confirmed large B-cell non-Hodgkin's lymphoma. This patient illustrates the importance of considering PCNSL in patients presenting with a space-occupying lesion, even with previously confirmed demyelination, and that the interval between the two events may be several years.en
dc.language.isoenen
dc.subject.otherAdulten
dc.subject.otherBrain Neoplasms.complications.pathology.radionuclide imagingen
dc.subject.otherDemyelinating Diseases.complicationsen
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherLymphoma, B-Cell.complications.pathology.radionuclide imagingen
dc.subject.otherLymphoma, Non-Hodgkin.complications.pathology.radionuclide imagingen
dc.subject.otherMagnetic Resonance Imagingen
dc.subject.otherPositron-Emission Tomographyen
dc.subject.otherPseudotumor Cerebri.complicationsen
dc.subject.otherTime Factorsen
dc.titleProlonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Clinical Neuroscienceen
dc.identifier.affiliationDepartment of Nuclear Medicine and Centre for PET, Austin Health, 145 Studley Road, Heidelberg, Melbourne, Victoria 3084, Australiaen
dc.identifier.doi10.1016/j.jocn.2006.05.003en
dc.description.pages1126-9en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/17890092en
dc.type.austinJournal Articleen
local.name.researcherRowe, Christopher C
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.languageiso639-1en-
crisitem.author.deptMolecular Imaging and Therapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Mar 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.